在加拿大寻求水痘疫苗最佳接种程序:利用基于智能体的模型探讨剂量时机、覆盖率和免疫力消退对疾病结局的影响
研究利用基于智能体的水痘疾病模型,在阿尔伯塔省75年时间跨度内比较无接种、长剂量间隔程序(首剂12月龄,第二剂4-6岁)和短剂量间隔程序(首剂12月龄,第二剂18月龄)对水痘和带状疱疹结局的影响。结果显示水痘疫苗接种大幅降低水痘发病率,短剂量间隔程序较长剂量间隔程序的水痘发病率显著更低、感染年龄更高、突破率更低但带状疱疹发病率更高。模型提示疫苗长期有效,剂量时机可能影响疾病结局和疫苗效果,但仅是决策考量之一。
要点
- 水痘疫苗接种在实施后75年内大幅降低水痘发病率。
- 短剂量间隔程序较长剂量间隔程序水痘发病率显著更低、感染年龄更高、突破率更低。
- 短剂量间隔程序的带状疱疹发病率较长剂量间隔程序更高。
核心结论
- 模型结果表明水痘疫苗长期有效,疫苗剂量时机可能影响疾病结局和疫苗效果。
- 疫苗剂量时机的效果仅是决策者实施水痘疫苗规划的考量之一,其他考量包括不良事件风险、程序对联合疫苗中其他抗原的影响、家长接受度和不同程序相关成本。
研究设计与样本
- 研究使用基于智能体的水痘疾病模型,在加拿大阿尔伯塔省75年时间跨度内测试三种接种情景:基线(不接种)、长剂量间隔程序(首剂12月龄,第二剂4-6岁)和短剂量间隔程序(首剂12月龄,第二剂18月龄)。
主要发现
- 水痘疫苗接种在实施后75年内导致水痘发病率大幅下降。
- 与长剂量间隔程序相比,短剂量间隔程序导致水痘发病率显著更低、水痘感染年龄更高、水痘突破率更低和带状疱疹发病率更高。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Many countries continue to consider implementing a universal chickenpox vaccine program; however, there is no consensus on the most appropriate and effective timing between vaccine doses. The chickenpox vaccine schedule debate is highlighted in Canada, where there are currently eight different vaccine schedules across the country. The objective of this study was to test the overall effectiveness of chickenpox vaccination, as well as the specific impact of two different vaccine schedules, on chickenpox disease outcomes in Alberta over 75 years. Using an agent-based model of chickenpox disease, we tested the impact of three vaccination scenarios including: baseline (no vaccination), a long dosing interval-Schedule LDI (1st dose - 12 months; 2nd dose - 4-6 years) and a short dosing interval-Schedule SDI (1st dose - 12 months; 2nd dose - 18 months) on chickenpox and shingles disease outcomes. Chickenpox vaccination led to a substantial decrease in chickenpox incidence over 75 years post-vaccine implementation. Compared to Schedule LDI, Schedule SDI resulted in a significantly lower chickenpox incidence, a higher age of chickenpox infection, a lower chickenpox breakthrough rate and a higher shingles incidence rate. Our model findings suggest that the chickenpox vaccine is effective over a long period of time and the dose timing of the vaccine may impact disease outcomes and vaccine effectiveness. However, the effectiveness of the vaccine dose timing is only one consideration for policy-makers who are implementing a chickenpox vaccine program, with others including risk of adverse events, the impact of the schedule on other antigens in a combination vaccine, parental acceptance and the cost associated with different schedules.
引用
- Rafferty ERS, McDonald W, Osgood ND, et al. Seeking the optimal schedule for chickenpox vaccination in Canada: Using an agent-based model to explore the impact of dose timing, coverage and waning of immunity on disease outcomes. Vaccine. 2019. PMID: 31735499. doi:10.1016/j.vaccine.2019.10.065
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。